{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-024530","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.124594+00:00","generated_at":"2026-06-01T11:27:38.573837+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Prime Medicine adopts Second Amended and Restated Bylaws with updated stockholder proposal procedures","bullets":["Board adopted Second A&R Bylaws effective May 17, 2024, superseding prior bylaws.","Revises advance notice procedures for stockholder proposals and director nominations.","Addresses universal proxy rules; requires compliance with Rule 14a-19 for non-Board nominees.","Clarifies Board meeting procedures including postponing, rescheduling, canceling stockholder meetings.","Updates routine, technical, and non-substantive provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-024530","json":"https://secwatch.observer/filing/0001628280-24-024530.json","markdown":"https://secwatch.observer/filing/0001628280-24-024530.md","text":"https://secwatch.observer/filing/0001628280-24-024530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024024530/0001628280-24-024530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024024530/prme-20240517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T11:27:38.573837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}